TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away

The Motley Fool Logo The Motley Fool By Jonathan Ponciano
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away

Commodore Capital fully exited its position in Scholar Rock, selling approximately 1.5 million shares in Q3, representing a $51 million transaction. The biotech company is preparing to resubmit its apitegromab biologics license application after a previous FDA rejection.

Insights
SRRK   neutral

Company is investing heavily in pipeline development, faced FDA rejection, but has cash runway into 2027 and preparing to resubmit biologics license application